M Benthe Muntinghe-Wagenaar

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Brain Metastases

Reactive Oxygen Species

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, Abraham Rutgers, Lucie B M Hijmering-Kappelle, Birgitta I Hiddinga, J Fred Ubbels, Robin Wijsman, Marcel J van der Leij, Johan Bijzet, Harry J M Groen, Huib A M Kerstjens, Anthonie J van der Wekken, Bart-Jan Kroesen, Thijo Jeroen N Hiltermann
Baseline Blood CD8 + T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer. Cancers 16 (14) (2024)
Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, Abraham Rutgers, Lucie B M Hijmering-Kappelle, Birgitta I Hiddinga, J Fred Ubbels, Robin Wijsman, Marcel J van der Leij, Johan Bijzet, Harry J M Groen, Huib A M Kerstjens, Anthonie J van der Wekken, Bart-Jan Kroesen, Thijo Jeroen N Hiltermann
Baseline Blood CD8 + T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer. Cancers 16 (14) (2024)
Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, Abraham Rutgers, Lucie B M Hijmering-Kappelle, Birgitta I Hiddinga, J Fred Ubbels, Robin Wijsman, Marcel J van der Leij, Johan Bijzet, Harry J M Groen, Huib A M Kerstjens, Anthonie J van der Wekken, Bart-Jan Kroesen, Thijo Jeroen N Hiltermann
Baseline Blood CD8 + T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer. Cancers 16 (14) (2024)